Search results

Socio-economic, health and environmental turbulences experienced during the past decades have caused major value chain disruptions, triggering multinational enterprises (MNEs) to rethink the footprints of their global operations and redesign for resilience. These developments have fueled a rapidly expanding scholarly literature on resilience. Yet, its conceptual understanding and practical utility remain highly fragmented, cross-disciplinarily disconnected and ambiguous. This study explores the intellectual structure of resilience research in business and management, relying on a systematic literature review approach based on bibliometric techniques and content analysis. A unique database consisting of 545 peer-reviewed articles published in 65 leading Academic Journal Guide (AJG) journals are analyzed. Based on the findings, three leading research communities dominate the resilience discussion in business and management. Moreover, the intellectual structure of the field through the most productive authors and top cited journal articles is discussed. Based on the results, five potential research avenues are suggested.

We review the conceptualization of quality of life (QOL) past and present, providing a new definition that transcends the traditional approach. We discuss the importance of QOL as a mandatory assessment in patient care and clinical trials, concurring with the need for disease-specific tools and focusing on a nerve fiber-specific tool for assessing impacts of diabetic neuropathies on QOL and activities of daily living (ADLs) used in multi-center clinical trials and translated into different languages. By relating neuropathic disabilities to different nerve fibers, the Norfolk Quality of Life – Diabetic Neuropathy (QOL-DN) is able to measure impacts of nerve-fiber-specific neurotrophic therapies, providing pertinent endpoints to changes in health status and QOL.

The neoclassical theory of investments, as formulated by Dale Jorgenson (1963, 1967), can be expressed in a fairly straightforward way.¹ Neoclassical formulations such as Jorgenson's were preceded by contributions by many influential economists. Both John Maynard Keynes and Irving Fisher, for example, argued that investments are made until the present value of expected future revenues, at the margin, equals the opportunity cost of capital. This means that investments are made until the net present value is equal to zero.